James Timpson, CEO of the UK-based retail chain Timpson, has reported a 680% increase in customers needing extra holes added to their belts. This unusual rise, observed in their stores this year, is being linked to the growing use of weight-loss medications like Mounjaro. Timpson suggests that as more people take these drugs, they are experiencing significant weight loss, which in turn is leading to a need for adjustments in clothing, including belts. Weight-loss medications such as semaglutide—marketed as Wegovy for weight loss and Ozempic for diabetes—and Mounjaro have gained popularity in recent years. These drugs work by reducing appetite and slowing digestion, helping individuals lose weight. However, access to these medications through the National Health Service (NHS) in the UK is limited, meaning many people opt to pay for them privately. Estimates suggest that around 2.4 million people in the UK are prescribed weight-loss medications, highlighting the scale of their use. The majority of those taking semaglutide and Mounjaro are paying out-of-pocket, as NHS restrictions mean these drugs are not widely available through public healthcare. This trend has led to increased demand for products and services related to weight loss, from clothing adjustments to fitness programs. In June, the UK’s medicines regulator approved Wegovy in tablet form, which could make the medication more accessible to some patients. This approval may further contribute to the growing trend of weight loss among those using these drugs, potentially impacting related industries such as retail and healthcare services.